124 related articles for article (PubMed ID: 9815609)
1. Stabilization of mammary-derived growth inhibitor messenger RNA by antiestrogens.
Huynh H; Pollak M
Clin Cancer Res; 1997 Nov; 3(11):2151-6. PubMed ID: 9815609
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
3. Suppression of mammary-derived growth inhibitor gene expression by growth hormone and insulin-like growth factor I.
Huynh H; Beamer W
Int J Oncol; 1998 Sep; 13(3):577-82. PubMed ID: 9683796
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes.
Huynh H; Alpert L; Pollak M
Cancer Res; 1996 Nov; 56(21):4865-70. PubMed ID: 8895735
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
6. Response of different mammary epithelial cell lines to a mammary derived growth inhibitor (MDGI).
Lehmann W; Widmaier R; Langen P
Biomed Biochim Acta; 1989; 48(1):143-51. PubMed ID: 2775246
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor.
Huynh HT; Larsson C; Narod S; Pollak M
Cancer Res; 1995 Jun; 55(11):2225-31. PubMed ID: 7757968
[TBL] [Abstract][Full Text] [Related]
8. The human mammary-derived growth inhibitor (MDGI) gene: genomic structure and mutation analysis in human breast tumors.
Phelan CM; Larsson C; Baird S; Futreal PA; Ruttledge MH; Morgan K; Tonin P; Hung H; Korneluk RG; Pollak MN; Narod SA
Genomics; 1996 May; 34(1):63-8. PubMed ID: 8661024
[TBL] [Abstract][Full Text] [Related]
9. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
10. Hormonal induction of functional differentiation and mammary-derived growth inhibitor expression in cultured mouse mammary gland explants.
Binas B; Spitzer E; Zschiesche W; Erdmann B; Kurtz A; Müller T; Niemann C; Blenau W; Grosse R
In Vitro Cell Dev Biol; 1992; 28A(9-10):625-34. PubMed ID: 1429365
[TBL] [Abstract][Full Text] [Related]
11. Antiprogestins inhibit growth and stimulate differentiation in the normal mammary gland.
Li M; Spitzer E; Zschiesche W; Binas B; Parczyk K; Grosse R
J Cell Physiol; 1995 Jul; 164(1):1-8. PubMed ID: 7790381
[TBL] [Abstract][Full Text] [Related]
12. Local control of mammary gland differentiation: mammary-derived growth inhibitor and pleiotrophin.
Kurtz A; Spitzer E; Zschiesche W; Wellstein A; Grosse R
Biochem Soc Symp; 1998; 63():51-69. PubMed ID: 9513711
[TBL] [Abstract][Full Text] [Related]
13. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
14. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
Long BJ; Jelovac D; Thiantanawat A; Brodie AM
Clin Cancer Res; 2002 Jul; 8(7):2378-88. PubMed ID: 12114443
[TBL] [Abstract][Full Text] [Related]
15. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells.
Ruohola JK; Valve EM; Karkkainen MJ; Joukov V; Alitalo K; Härkönen PL
Mol Cell Endocrinol; 1999 Mar; 149(1-2):29-40. PubMed ID: 10375015
[TBL] [Abstract][Full Text] [Related]
17. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780.
Huynh H; Yang XF; Pollak M
Cell Growth Differ; 1996 Nov; 7(11):1501-6. PubMed ID: 8930399
[TBL] [Abstract][Full Text] [Related]
18. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.
Huynh H; Pollak M
Cancer Res; 1994 Jun; 54(12):3115-9. PubMed ID: 7515764
[TBL] [Abstract][Full Text] [Related]
19. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474.
Luo LY; Grass L; Diamandis EP
Anticancer Res; 2000; 20(2A):981-6. PubMed ID: 10810385
[TBL] [Abstract][Full Text] [Related]
20. Mammary-derived growth inhibitor alters traffic of EGFR and induces a novel form of cetuximab resistance.
Nevo J; Mattila E; Pellinen T; Yamamoto DL; Sara H; Iljin K; Kallioniemi O; Bono P; Heikkilä P; Joensuu H; Wärri A; Ivaska J
Clin Cancer Res; 2009 Nov; 15(21):6570-81. PubMed ID: 19825952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
